EFFECT OF GLYCYRRHIZA GLABRA ON THE LIVER OF PREGNANT MICE
Abstract
In the present study the Swiss white female mice were obtained from the department of Anatomy and the central animal house, Institute of medical sciences, Banaras Hindu University. Each group of experimental animal received, orally, 400mg/kg body weight of the drug with 0.5mlof distilled water, whereas the control mice of each group received the same volume of distilled water. The first group was treated with daily single oral dose of the Glycyrrhiza glabra for 1-3 days of gestation, the second group with daily dose of the same drug for 1-7days, whereas the third treated group received single dose from 1-17 days of gestation. All groups of pregnant mice were sacrificed on day 18th of gestation i.e. one day prior to delivery. The liver of the female pregnant mice were collected after laparotomy and observed for gross malformation, but there were no any external abnormalities in any treated group as compared to the control. The weight of the liver of the first and second group showed no significant change as compared with their corresponding controls, whereas in the third group there was significant increased in the weight compared with control.
Microscopic examination of treated liver of first group was appeared to be normal as compared with the control group, whereas second group & third group showed dilation of and destruction of endothelial lining of central vein along with necrosis of hepatocytes. The pericentral necrosis was also observed in the third group.
Keywords
Full Text:
PDFReferences
Saxena S. (2005). “Glycyrrhiza glabra: Medicine over the millennium”, Natural products Radiance, Vol.4(5), September –October.
Okimasu E, Moromizato Y, and Watanabe S. (1983). “Inhibition of phospolipase A2 and platelet aggregation by glycyrrhizine, an antiinflamation drug”, Acta Med Okayam, Vol.37, pp.385-391.
Goso Y, Ogata Y, Ishihara K, and Hotta K. (1996). “Effectsof traditional herbal medicine on gastric mucin against ethanol induced gastric injuryin rats”, Comp Biochem Physiol Pharmacol Toxicol Endocrinol, Vol.113, pp.17-21.
Ghanekar BG, and Sushruta samhita. (2006). “Sharir sthan”, Meharchand Lachhmandas Publications, New Delhi; India; Edition.10, p.309.
Shibata S. (1994). Int J Pharmacog, Vol.32(1), pp.75-89.
Isbruker RA, and Burdock GA. (2006). “Risk and safety assessment on th consumption of licorice roots ,its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicity of glycyrrhizin”, Regul toxicol pharmacol, Vol.46(3), pp.167-192.
Chin YW, and Nixon DW. (2001). “Licorice and cancer”, Nutr cancer. Vol.39(1), pp.1-11.
Bateman, J, Chapman R.D, and Simpson D. (1998). “Possible toxicity of herbal remedies”, Scott. Med. J., Vol.43(1), pp.7-15.
Catherine CC, and Thomas NW. (1998). “User of herbal medicine.Among consultationaliais on populations: a review of current information regarding risk interaction and efficacy”, Psychosomatics, Vol.39, pp.3-13.
Tripathi YB, Tiwari OP, Nagwani S, and Mishra B. (2009). “Pharmacokinetic interaction of vitex nigundo linn and paracetamol”, Ind.J. Med.Res, Vol.130, pp.45-49.
Van Rossum TG, Vulto AG, Hop WC, and Schalm SW. (2001). “Glycyrrhizin –induced reduction of ALT in European patients with chronic hepatitis C”, Am J Gastroenterol, Vol.96, pp.2432-2437.
Kumuda H. (2002). “Long term treatment of chronic hepatitis C with Glycyrrhizin for preventing liver cirrhosis and hepatocellular carcinoma”, Ooncology. Vol.62, pp.94-100.
Alaaedin A, Hamza. (2007). “Curcuma longa. Glycyrrhiza glabra and Moringa oleifra Ameliorate Diclofenacinduced Hepatotoxicity in rats”, American Journal of Pharmacology and Toxicology, Vol.2(2), pp.80-88.
Kumar V, Kumar S, Shashidharan. Anitha, Manjula. (2011). “Comparision of the Antioxidant Capacity of an Important Hepatoprotective Plants”, International Journal of Pharmaceutical Sciences and Drug research, Vol.3(1), pp.48-51.
Bernardi M, Paola E, D’Intio F,Trevisani G,Cantelli-forti A, Raggi E, and Turchetto G. Gasbarrini. (1994). “Effect of prolonged ingestion of graded doses of licorice by healthy volunteers”, Life Sciences, Vol.55(11), pp.863-872.
Stormer FC, Reistad R, and Alexander J. (1993). “Glycyrrhizic acid in Licorice- evaluation of health hazards”, Food chemical and Toxicol, Vol.31, pp.303-312.
Newall CA, Anderson LA, and Phillipson JD. (1996). “Herbal Medicines: A Guide for Health Care Professionals”, Pharmceutical Press, London.
Ernst E. (2000). “Herbal Medicine Products During Pregnancy : Are They Safe?”, BJOG, Vol.109, pp.227-235.
Strandberg TE, Andersson S, and Jarvenpaa AL. (2003). “Risk factors for preterm delivery”, Lancet, 361(9355).
Dayanand B, Raghavan A, Khanum K, and Singh B. (2010). “In vitro antioxidant and free radical scavenging activity of Glycyrrhiza glabra root extracts”, Journal of herbal medicine and toxicology, Vol.4(1), pp.97-102.
Refbacks
- There are currently no refbacks.
Send mail to ijmpr@ijmpr.com with questions or comments about this web site.
International Journal of Medical and Pharma Research, All rights reserved.